共 50 条
- [41] Incremental usefulness of genetic testing of clopidogrel therapy over conventional clinical risk factors for prediction of major cardiovascular events after drug-eluting stent implantationEUROPEAN HEART JOURNAL, 2014, 35 : 1164 - 1164Park, M-W.Her, H. S. H.Cho, C. J. S.Kim, K. C. J.Park, P. K. M.Chang, C. K. U.Seung, S. K. B.Kim, K. P. J.Chung, C. W. S.
- [42] Clinical and Genetic Risk Factors for Drug-Induced Liver Injury Associated with Anti-Tuberculosis Treatment-A Study from Patients of Portuguese Health CentersJOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (05):Cavaco, Maria JoaoAlcobia, CelesteOliveiros, BarbaraMesquita, Luis AlcidesCarvalho, AuroraMatos, FernandoCarvalho, Jose MiguelVillar, MiguelDuarte, RaquelMendes, JoaoRibeiro, CarolinaCordeiro, Carlos RobaloRegateiro, FernandoSilva, Henriqueta Coimbra
- [43] The impact of applying various de novo assembly and correction tools on the identification of genome characterization, drug resistance, and virulence factors of clinical isolates using ONT sequencingBMC Biotechnology, 23Hussain A. SafarFatemah AlatarKother NasserRehab Al-AjmiWadha AlfouzanAbu Salim Mustafa
- [44] The impact of applying various de novo assembly and correction tools on the identification of genome characterization, drug resistance, and virulence factors of clinical isolates using ONT sequencingBMC BIOTECHNOLOGY, 2023, 23 (01)Safar, Hussain A.Alatar, FatemahNasser, KotherAl-Ajmi, RehabAlfouzan, WadhaMustafa, Abu Salim
- [45] Clinical and genetic risk factors for the development of multi-drug resistant tuberculosis in non-HIV infected patients at a tertiary care center in India: a case-control studyINFECTION GENETICS AND EVOLUTION, 2003, 3 (03) : 183 - 188Sharma, S. K.Turaga, K. K.Balamurugan, A.Saha, P. K.Pandey, R. M.Jain, N. K.Katoch, V. M.Mehra, N. K.
- [46] Identification of risk factors for carbamazepine-induced serious mucocutaneous adverse reactions: A case-control study using data from spontaneous adverse drug reaction reportsJOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2014, 5 (02) : 100 - 138Bertulyte, IlmaSchwan, SofieHallberg, Par
- [47] Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential StudyRHEUMATOLOGY, 2011, 50 (01) : 40 - 46Iannaccone, Christine K.Lee, Yvonne C.Cui, JingFrits, Michelle L.Glass, Roberta J.Plenge, Robert M.Solomon, Daniel H.Weinblatt, Michael E.Shadick, Nancy A.
- [48] Identification of Three Genetic Risk Factors for Venous Thrombosis Using a Multiplex Allele-Specific PCR Assay: Comparison of Conventional and New Alternative Methods for the Preparation of DNA from Clinical SamplesJournal of Thrombosis and Thrombolysis, 2003, 16 : 189 - 193Antonio AngeliniConcetta Di FebboGiovanna BaccanteMarcello Di NisioCarmine Di IlioFranco CuccurulloEttore Porreca
- [49] Identification of three genetic risk factors for venous thrombosis using a multiplex allele-specific PCR assay: Comparison of conventional and new alternative methods for the preparation of DNA from clinical samplesJOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2003, 16 (03) : 189 - 193Angelini, ADi Febbo, CBaccante, GDi Nisio, MDi Ilio, CCuccurullo, FPorreca, E
- [50] Application of clinical pharmacology in pharmacoeconomics: Economic evaluation of HMG-COA reductase inhibitors using pragmatic head-to-head randomized controlled trials with up-titration of drug doses to obtain therapeutic targets for LDL-cholesterol.CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S76 - S76Farahani, P.